2m 2m 2m 2m 2m 2m 2m
- $160.5MMarket Cap
- -18.05%1-Year Change
- OtherIndustry
ORGANIGRAM GLOB (OGI)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 18
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Organigram Bets Big On Europe With Sanity Group Takeover
Organigram Global announced a proposed acquisition of Sanity Group, a German cannabis company, for €113.4 million upfront plus up to €113.8 million in earnout consideration. The deal aims to establish Organigram as a global cannabis pure-play with significant European market presence. Funding will come from cash on hand, a new credit facility, and a €47.8 million investment from British American Tobacco. OGI shares rose 7.09% in premarket trading, though technical indicators show bearish short-to-medium term trends.
02/18/2026, 7:26 AM • Benzinga
OrganiGram (OGI) Joins Cannabis Stock Rally After Trump Signals Policy Shift
OrganiGram's stock surged 15% after former President Trump's social media post suggesting potential health benefits of cannabis and a possible shift in federal drug policy, boosting optimism in the cannabis industry.
09/29/2025, 4:02 PM • Benzinga
Peers
Statistics
MoreInformation as of 06/02/2026
Company Profile
Organigram Global Inc is a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada. It is is focused on producing high-quality cannabis for adult recreational consumers. It has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Superieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba.
Key Executives
- James H. Yamanaka
- Timothy Emberg
- Greg Guyatt
- Helen Martin
- Paolo De Luca
Current Ownership Distribution
- Institutions274.3M (68.27%)
- Mutual Funds127.5M (31.73%)
- Insiders0 (0.00%)
- Other0 (0.00%)